176 related articles for article (PubMed ID: 29912618)
1. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model.
Simone BA; Palagani A; Strickland K; Ko K; Jin L; Lim MK; Dan TD; Sarich M; Monti DA; Cristofanilli M; Simone NL
Cell Cycle; 2018; 17(13):1536-1544. PubMed ID: 29912618
[TBL] [Abstract][Full Text] [Related]
2. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.
Simone BA; Dan T; Palagani A; Jin L; Han SY; Wright C; Savage JE; Gitman R; Lim MK; Palazzo J; Mehta MP; Simone NL
Cell Cycle; 2016 Sep; 15(17):2265-74. PubMed ID: 27027731
[TBL] [Abstract][Full Text] [Related]
3. Effects of calorie restriction and IGF-1 receptor blockade on the progression of 22Rv1 prostate cancer xenografts.
Galet C; Gray A; Said JW; Castor B; Wan J; Beltran PJ; Calzone FJ; Elashoff D; Cohen P; Aronson WJ
Int J Mol Sci; 2013 Jul; 14(7):13782-95. PubMed ID: 23823800
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
[TBL] [Abstract][Full Text] [Related]
5. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
Liu J; Chen X; Ward T; Pegram M; Shen K
Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
[TBL] [Abstract][Full Text] [Related]
6. Caloric restriction augments radiation efficacy in breast cancer.
Saleh AD; Simone BA; Palazzo J; Savage JE; Sano Y; Dan T; Jin L; Champ CE; Zhao S; Lim M; Sotgia F; Camphausen K; Pestell RG; Mitchell JB; Lisanti MP; Simone NL
Cell Cycle; 2013 Jun; 12(12):1955-63. PubMed ID: 23708519
[TBL] [Abstract][Full Text] [Related]
7. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
8. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.
Lee JO; Kang MJ; Byun WS; Kim SA; Seo IH; Han JA; Moon JW; Kim JH; Kim SJ; Lee EJ; In Park S; Park SH; Kim HS
Breast Cancer Res; 2019 Oct; 21(1):115. PubMed ID: 31640742
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
Jin K; Pandey NB; Popel AS
Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
11. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
[TBL] [Abstract][Full Text] [Related]
12. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster.
Jin L; Lim M; Zhao S; Sano Y; Simone BA; Savage JE; Wickstrom E; Camphausen K; Pestell RG; Simone NL
Breast Cancer Res Treat; 2014 Jul; 146(1):41-50. PubMed ID: 24863696
[TBL] [Abstract][Full Text] [Related]
13. Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.
Singh M; Ramos I; Asafu-Adjei D; Quispe-Tintaya W; Chandra D; Jahangir A; Zang X; Aggarwal BB; Gravekamp C
Cancer Med; 2013 Aug; 2(4):571-82. PubMed ID: 24156030
[TBL] [Abstract][Full Text] [Related]
14. Nutritional supplements in combination with chemotherapy or targeted therapy reduces tumor progression in mice bearing triple-negative breast cancer.
Guo CH; Hsia S; Chung CH; Lin YC; Shih MY; Chen PC; Peng CL; Henning SM; Hsu GW; Li Z
J Nutr Biochem; 2021 Jan; 87():108504. PubMed ID: 32956826
[TBL] [Abstract][Full Text] [Related]
15. Replenishment of myeloid-derived suppressor cells (MDSCs) overrides CR-mediated protection against tumor growth in a murine model of triple-negative breast cancer.
Pomatto-Watson LCD; Bodogai M; Carpenter M; Chowdhury D; Krishna P; Ng S; Bosompra O; Kato J; Wong S; Reyes-Sepulveda C; Bernier M; Price NL; Biragyn A; de Cabo R
Geroscience; 2022 Oct; 44(5):2471-2490. PubMed ID: 35996062
[TBL] [Abstract][Full Text] [Related]
16. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
17. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.
Brandhorst S; Wei M; Hwang S; Morgan TE; Longo VD
Exp Gerontol; 2013 Oct; 48(10):1120-8. PubMed ID: 23454633
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
Martin JL; Julovi SM; Lin MZ; de Silva HC; Boyle FM; Baxter RC
Breast Cancer Res; 2017 Aug; 19(1):90. PubMed ID: 28778177
[TBL] [Abstract][Full Text] [Related]
19. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
20. Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene.
Yan Y; Li XQ; Duan JL; Bao CJ; Cui YN; Su ZB; Xu JR; Luo Q; Chen M; Xie Y; Lu WL
Int J Nanomedicine; 2019; 14():3645-3667. PubMed ID: 31190817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
